Search
Lansoprazole Action Pathway (old)
smpdb.ca/view/SMP0000227Drug actionLansoprazole, sold as Prevacid, is a proton pump inhibitor (PPI) class drug that suppresses the final step in gastric acid production. In this pathway, lansoprazole is taken orally and is oxidized in the stomach to form the active metabo...
Enzymes: Histamine H2 receptorPirenzepine M1 Ulcer Treatment Action Pathway
smpdb.ca/view/SMP0124706Drug actionPirenzepine is a drug that targets antimuscarinic agents in order to treat ulcers, this is done through inhibiting gastic secretions in order to allow the ulver to heal. Pirenzepine belongs to antispasmodics and anticholinergics group, t...
Enzymes: Histamine H2 receptorDoxylamine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0058803Drug actionFurthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release. … H1-antihistamines interfere with the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory process in order to treat conditions such as allergic rhinitis, allergic
Enzymes: Histamine H1 receptorDexbrompheniramine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175073Drug actionFurthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release. … H1-antihistamines interfere with the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory process in order to treat conditions such as allergic rhinitis, allergic
Enzymes: Histamine H1 receptorCyproheptadine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175075Drug actionFurthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release. … H1-antihistamines interfere with the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory process in order to treat conditions such as allergic rhinitis, allergic
Enzymes: Histamine H1 receptorPromethazine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175084Drug actionFurthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release. … H1-antihistamines interfere with the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory process in order to treat conditions such as allergic rhinitis, allergic
Enzymes: Histamine H1 receptorChloropyramine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175097Drug actionFurthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release. … H1-antihistamines interfere with the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory process in order to treat conditions such as allergic rhinitis, allergic
Enzymes: Histamine H1 receptorAcrivastine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175099Drug actionFurthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release. … H1-antihistamines interfere with the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory process in order to treat conditions such as allergic rhinitis, allergic
Enzymes: Histamine H1 receptorEbastine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175100Drug actionFurthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release. … H1-antihistamines interfere with the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory process in order to treat conditions such as allergic rhinitis, allergic
Enzymes: Histamine H1 receptorQuetiapine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175112Drug actionFurthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release. … H1-antihistamines interfere with the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory process in order to treat conditions such as allergic rhinitis, allergic
Enzymes: Histamine H1 receptor